JAKARTA, KOMPAS.com – Indonesia’s Covid-19 Task Force maintained that vaccines in Indonesia, such as Sinovac and AstraZeneca, can effectively resist coronavirus mutations such as the Delta variant from India that is found in the country.
The Jakarta Provincial administration announced that it will continue plans for face-to-face classes, though three schools shut down the program after their teachers tested positive for Covid-19.
And the State Intelligence Agency or BIN estimated that 85 percent of young people have been exposed to radical thinking, particularly on social media. This and more on Indonesia Highlights:
Indonesia’s Covid-19 Task Force: Vaccines Effective Against All Covid-19 Variants
Indonesian Covid-19 Task Force spokesman Wiku Adisasmito has assured the Indonesian public that Covid-19 vaccines used in Indonesia are effective in protecting against the Delta variant of Covid-19 or B.1.617.2, as well as other coronavirus strains.
“The effectiveness rate of the Covid-19 vaccines used in Indonesia, such as Sinovac and AstraZeneca, is higher than 50 percent," he said on Tuesday.
However, Wiku noted that “like all viruses, Covid-19 mutates to defend itself. The mutation process will occur constantly as long as the potential for transmission exists".
Indonesian Minister of Health Budi Gunadi Sadikin confirmed that the Delta variant of Covid-19 is one of the most widely spread strains of the coronavirus in Indonesia.
“The Delta strain of the coronavirus is found in Jakarta, after it was identified as the source of coronavirus clusters in Kudus Regency, Central Java and Bangkalan Regency on East Java province’s Madura Island.”
Budi noted that the transmission of the Delta variant of the coronavirus is quicker, though not more deadly, than other Covid-19 strains such as the Alpha strain from Great Britain or the Beta variant from South Africa.